Acquisition of doxorubicin resistance in human leukemia HL-60 cells is reproducibly associated with 7q21 chromosomal anomalies

Tumor cell resistance to doxorubicin (DOX(3)) is usually associated with the overexpression of P-glycoprotein (PGP) in model systems. We have characterized the karyotypic changes in two sublines of HL-60 cells which differ in the induction of differentiation by retinoic acid. The parental sublines, designated HL-60A/S and HL-60Y/S, were selected in increasing concentrations of 0.025-0.1: mu g/mL DOX. Monosomy 8 in HL-60Y/S was the only karyotypic difference prior to DOX exposure, Both sublines acquired 7q+ markers upon exposure to DOX. In HL-60Y/S, an add(7)(q21) replaced one homologue at 0.025 mu g/mL DOX, and an add(7)(q32) appeared which replaced the other normal 7 at 0.05 mu g/mL DOX. The HL-60A/S cells acquired an add(7)(q21) at 0.025 mu g/mL DOS. The 7q+ abnormalities involved breakpoints in the midregion of 7q. The overexpression of phosphorylated PGP in immunoprecipitates with C-219 antibody was identified in both sublines of DOX-resistant HL-60 cells with 7q+ abnormalities, and this is consistent with the location of mdr-1 sequences to 7q21-21.1. Also, analysis of RNA from parental-sensitive and DOX-resistant sublines by reverse transcriptase;polymerase chain reaction revealed: a) comparable expression of multidrug resistance related protein (MRP) in sensitive and resistant sublines; and b) overexpression of mdr-1 only in the DOX-resistant sublines, Thus, the selection of DOX resistance in two sublines of NL-60 cells which differ in their response to retinoic-acid-induced myeloid differentiation is reproducibly associated with overexpression of mdr-1 versus MRP.